Gastrointestinal Cancer
From the Journals
Studies eye adjuvant therapy in locally advanced rectal cancer
After a median follow-up of more than 3 years, hazard ratios for overall survival were 0.44 and 0.50, favoring adjuvant chemotherapy.
Daily News Podcast
MDedge Daily News: Can a nasal spray reverse suicidality?
And pain relievers and inflammatory bowel disease? It’s complicated.
From the Journals
Healthy lifestyle linked to better colon cancer survival
Five-year colon cancer survival probability was 85% for highly ACS guideline–adherent patients and 76% for patients with low adherence.
Conference Coverage
Enhanced recovery led to fewer complications for major oncologic procedures
CHICAGO – A study has found that enhanced recovery protocols are safe and feasible in major abdominal operations beyond colorectal surgery.
Daily News Podcast
MDedge Daily News: Diabetes patients ignore a deadly risk
And a three-in-one pill could change hypertension treatment.
The JCSO Interview
Gastrointestinal cancers: new standards of care from landmark trials
From the Journals
CtDNA agrees (mostly) with tissue analysis in mCRC
In a prospective study, concordance was high when comparing RAS mutation analyses from plasma and tissue in 412 mCRC patients.
Conference Coverage
No increased complication risk with delaying resection for LARC
CHICAGO – Surgical resection for locally advanced rectal cancer at up to 12 weeks after neoadjuvant therapy did not increase complication risk.
Daily News Podcast
MDedge Daily News: Antibiotic resistance leads to ‘nightmare’ bacteria
And Medicare formulary changes could be on the way.
Daily News Podcast
MDedge Daily News: Could gut bacteria trigger lupus?
And acid suppressors in infancy could fuel allergies later on.
Conference Coverage
Accuracy of colon cancer lymph node sampling influenced by location
CHICAGO – A multicenter trial shows that left-sided colon cancer requires sampling more lymph nodes than does right-sided disease for true nodal...